Alberto Barbabosa Pliego
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alberto Barbabosa Pliego has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Abdelfattah Z.M. Salem
Faculty of Veterinary Medicine and Zootechnics, Autonomous University of the State of Mexico, Toluca, Edo de México, Mexico
1 shared publicationAmeer Khusro
Research Department of Plant Biology and Biotechnology, Loyola College, Nungambakkam, Chennai, Tamil Nadu, India
1 shared publicationBárbara Lizeth Miranda Jiménez
Faculty of Sciences, Autonomous University of the State of Mexico, Toluca, Edo de México, Mexico
1 shared publicationDeli Nazmín Tirado González
National Center of Disciplinary Research Familiar Agriculture (CENID AF), National Institute for Forestry, Agriculture and Livestock Research (INIFAP), Ojuelos de Jalisco, Jalisco, Mexico
1 shared publicationEdson Brodeli Figueroa Pacheco
Academic Unit of Agricultural and Environmental Sciences, Autonomous University of Guerrero, Iguala de la Independencia, Guerrero, Mexico
1 shared publicationErasto Desales‐Salazar
Centro de Investigación y Estudios Avanzados en Salud Animal (CIESA), Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma del Estado de México (UAEM), Toluca, Mexico
1 shared publication
Latest Publications
- 1 October 2021
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 105, 103717
Use of Antibiotics in Equines and Their Effect on Metabolic Health and Cecal Microflora Activities
- 1 October 2021
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 105, 103717
Use of Antibiotics in Equines and Their Effect on Metabolic Health and Cecal Microflora Activities
- 5 April 2020
- Published by Wiley in Journal of Applied Toxicology
- Vol. 40 (10) , 1310-1324
Scorpion venoms and associated toxins as anticancer agents: update on their application and mechanism of action
Cancer remains one of the deadliest non‐infectious diseases of the 21st century, causing millions of mortalities per year worldwide. Analyses of conventional treatments, such as radiotherapy and chemotherapy, have shown not only a lower therapeutic efficiency rate but also plethora of side‐effects. Considering the desperate need to identify promising anticancer agents, researchers are in quest to design and develop new tumoricidal drugs from natural sources. Over the past few years, scorpion venoms have shown exemplary roles as pivotal anticancer agents. Scorpion venoms associated metabolites, particularly toxins demonstrated in vitro anticancer attributes against diversified cell lines by inhibiting the growth and progression of the cell cycle, inhibiting metastasis by blocking ion channels such as K+ and Cl−, and/or inducing apoptosis by intrinsic and extrinsic pathways. This review sheds light not only on in vitro anticancer properties of distinct scorpion venoms and their toxins, but also on their mechanism of action for designing and developing new therapeutic drugs in future.
- 5 April 2020
- Published by Wiley in Journal of Applied Toxicology
- Vol. 40 (10) , 1310-1324
Scorpion venoms and associated toxins as anticancer agents: update on their application and mechanism of action
Cancer remains one of the deadliest non‐infectious diseases of the 21st century, causing millions of mortalities per year worldwide. Analyses of conventional treatments, such as radiotherapy and chemotherapy, have shown not only a lower therapeutic efficiency rate but also plethora of side‐effects. Considering the desperate need to identify promising anticancer agents, researchers are in quest to design and develop new tumoricidal drugs from natural sources. Over the past few years, scorpion venoms have shown exemplary roles as pivotal anticancer agents. Scorpion venoms associated metabolites, particularly toxins demonstrated in vitro anticancer attributes against diversified cell lines by inhibiting the growth and progression of the cell cycle, inhibiting metastasis by blocking ion channels such as K+ and Cl−, and/or inducing apoptosis by intrinsic and extrinsic pathways. This review sheds light not only on in vitro anticancer properties of distinct scorpion venoms and their toxins, but also on their mechanism of action for designing and developing new therapeutic drugs in future.